首页> 外国专利> ANALYSIS METHOD FOR TUMOR-INFILTRATING T-CELL REPERTOIRE AND DETERMINATION METHOD FOR EFFECTIVENESS OF CANCER THERAPEUTIC TREATMENT USING SAID ANALYSIS METHOD

ANALYSIS METHOD FOR TUMOR-INFILTRATING T-CELL REPERTOIRE AND DETERMINATION METHOD FOR EFFECTIVENESS OF CANCER THERAPEUTIC TREATMENT USING SAID ANALYSIS METHOD

机译:肿瘤浸润性T细胞库分析方法及有效治疗方法的SAAD分析法

摘要

Disclosed is a means that can be carried out in clinical scene of cancer therapy and is useful for determination of the effectiveness of a cancer therapeutic treatment. The analysis method for a tumor-infiltrating TCR (T-cell receptor) repertoire according to the present invention analyzes a tumor-infiltrating CD4-positive/CD8-positive TCR repertoire by annotation of a TCR repertoire of an unfractionated tumor tissue specimen that has not been subjected to a T-cell separation process, using a CD4-positive /CD8-positive TCR repertoire of a peripheral blood or tumor-draining lymph node specimen as a reference. By the analysis method, even when a primary or metastatic cancer lesion is so small that a sufficient amount of a tissue specimen for conventional TCR repertoire analysis cannot be collected, the TCR repertoire of tumor-infiltrating T cells can be analyzed using a small amount of a tissue specimen to obtain information for determining the effectiveness of a cancer therapeutic treatment.
机译:公开了一种可以在癌症治疗的临床现场中进行的手段,并且对于确定癌症治疗方法的有效性是有用的。根据本发明的肿瘤浸润TCR(T细胞受体)库的分析方法通过注释未分化的肿瘤组织标本的TCR库来分析肿瘤浸润的CD4阳性/ CD8阳性TCR库。使用外周血或引流肿瘤的淋巴结标本的CD4阳性/ CD8阳性TCR样本进行T细胞分离。通过这种分析方法,即使原发性或转移性癌病灶很小,以致于无法收集到足够数量的用于常规TCR库分析的组织标本,也可以使用少量的TCR来分析肿瘤浸润T细胞的TCR库。组织样本,以获得用于确定癌症治疗效果的信息。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号